J. Wang

机构：Nanjing University of Chinese Medicine, Sun Yat-sen University, Hangzhou Normal University, Henan University of Science and Technology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nankai University, Peking Union Medical College Hospital, Zhengzhou University, Zhengzhou University of Science and Technology, Chengdu Military General Hospital, Third Affiliated Hospital of Sun Yat-sen University, Southwest Jiaotong University · ORCID：0000-0002-0070-1320

发表论文 79 篇 · 总被引 921 次 · h-index 17

代表论文

Intergranular corrosion of Ni-30Cr in high-temperature hydrogenated water after removing surface passivating film (2024 · npj Materials Degradation · 被引 19)
Businesses marketing purported stem cell treatments and exosome therapies for COVID-19: An analysis of direct-to-consumer online advertising claims (2023 · Stem Cell Reports · 被引 9)
Community co-design to target diabetes and metabolic syndrome in Australian Indigenous peoples (2023 · Nature Medicine · 被引 9)
Safety and Efficacy Claims Made by US Businesses Marketing Purported Stem Cell Treatments and Exosome Therapies (2023 · Regenerative Medicine · 被引 8)
PHENYX – A flexible pipetting-based platform for automated microvolume radiochemistry (2022 · Chemical Engineering Journal · 被引 8)
LBA43 GEMSTONE-301: A randomized, double-blind, placebo-controlled, phase III study of sugemalimab in patients with unresectable stage III non-small cell lung cancer (NSCLC) who had not progressed after concurrent or sequential chemoradiotherapy (CRT) (2021 · Annals of Oncology · 被引 6)